CN110106142B - 一种制备“百亿”级脂肪源再生细胞的生产工艺 - Google Patents
一种制备“百亿”级脂肪源再生细胞的生产工艺 Download PDFInfo
- Publication number
- CN110106142B CN110106142B CN201910465622.4A CN201910465622A CN110106142B CN 110106142 B CN110106142 B CN 110106142B CN 201910465622 A CN201910465622 A CN 201910465622A CN 110106142 B CN110106142 B CN 110106142B
- Authority
- CN
- China
- Prior art keywords
- cells
- inoculation
- cell
- volume
- adipose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001172 regenerating effect Effects 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title description 4
- 238000011081 inoculation Methods 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 51
- 238000004113 cell culture Methods 0.000 claims abstract description 28
- 230000010412 perfusion Effects 0.000 claims abstract description 12
- 210000004027 cell Anatomy 0.000 claims description 116
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 34
- 239000003636 conditioned culture medium Substances 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 13
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 10
- 230000004069 differentiation Effects 0.000 claims description 10
- 239000012091 fetal bovine serum Substances 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 9
- 239000012737 fresh medium Substances 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000004115 adherent culture Methods 0.000 claims description 7
- 239000006143 cell culture medium Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 210000002919 epithelial cell Anatomy 0.000 claims description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 2
- 210000002865 immune cell Anatomy 0.000 claims description 2
- 210000000229 preadipocyte Anatomy 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 30
- 230000003321 amplification Effects 0.000 abstract description 17
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 17
- 102000008186 Collagen Human genes 0.000 abstract description 5
- 108010035532 Collagen Proteins 0.000 abstract description 5
- 229920001436 collagen Polymers 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 238000012136 culture method Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
- 239000002054 inoculum Substances 0.000 description 7
- 238000010899 nucleation Methods 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 239000007640 basal medium Substances 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 239000012679 serum free medium Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 3
- 230000009815 adipogenic differentiation Effects 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000004700 fetal blood Anatomy 0.000 description 3
- 150000002597 lactoses Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000009818 osteogenic differentiation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 210000004504 adult stem cell Anatomy 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/16—Particles; Beads; Granular material; Encapsulation
- C12M25/18—Fixed or packed bed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Computer Hardware Design (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910465622.4A CN110106142B (zh) | 2019-05-30 | 2019-05-30 | 一种制备“百亿”级脂肪源再生细胞的生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910465622.4A CN110106142B (zh) | 2019-05-30 | 2019-05-30 | 一种制备“百亿”级脂肪源再生细胞的生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110106142A CN110106142A (zh) | 2019-08-09 |
CN110106142B true CN110106142B (zh) | 2020-05-12 |
Family
ID=67493142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910465622.4A Active CN110106142B (zh) | 2019-05-30 | 2019-05-30 | 一种制备“百亿”级脂肪源再生细胞的生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110106142B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021217297A1 (zh) * | 2020-04-26 | 2021-11-04 | 深圳阿尔法生物科技有限公司 | 一种制备"百亿"级脂肪源再生细胞的生产工艺 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102321566A (zh) * | 2011-09-13 | 2012-01-18 | 协和干细胞基因工程有限公司 | 一种体外大量扩增细胞系以及间充质干细胞的方法 |
CN102861329A (zh) * | 2012-09-19 | 2013-01-09 | 武汉中博生物股份有限公司 | 一种利用生物反应器生产犬细小病毒灭活疫苗的方法 |
CN103849597A (zh) * | 2012-12-05 | 2014-06-11 | 上海坤爱生物科技有限公司 | 脂肪干细胞的规模化生产工艺 |
CN104974984A (zh) * | 2015-04-13 | 2015-10-14 | 深圳市默赛尔生物医学科技发展有限公司 | 一种脂肪组织来源的间充质干细胞的扩增培养方法 |
CN108348555A (zh) * | 2015-09-08 | 2018-07-31 | 赛尔爱迪尔私人有限公司 | 细胞扩增方法和治疗组合物 |
CN109496236A (zh) * | 2016-06-06 | 2019-03-19 | 普拉里斯坦有限公司 | 改变的粘附基质细胞及其产生和使用方法 |
-
2019
- 2019-05-30 CN CN201910465622.4A patent/CN110106142B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102321566A (zh) * | 2011-09-13 | 2012-01-18 | 协和干细胞基因工程有限公司 | 一种体外大量扩增细胞系以及间充质干细胞的方法 |
CN102861329A (zh) * | 2012-09-19 | 2013-01-09 | 武汉中博生物股份有限公司 | 一种利用生物反应器生产犬细小病毒灭活疫苗的方法 |
CN103849597A (zh) * | 2012-12-05 | 2014-06-11 | 上海坤爱生物科技有限公司 | 脂肪干细胞的规模化生产工艺 |
CN104974984A (zh) * | 2015-04-13 | 2015-10-14 | 深圳市默赛尔生物医学科技发展有限公司 | 一种脂肪组织来源的间充质干细胞的扩增培养方法 |
CN108348555A (zh) * | 2015-09-08 | 2018-07-31 | 赛尔爱迪尔私人有限公司 | 细胞扩增方法和治疗组合物 |
CN109496236A (zh) * | 2016-06-06 | 2019-03-19 | 普拉里斯坦有限公司 | 改变的粘附基质细胞及其产生和使用方法 |
Non-Patent Citations (3)
Title |
---|
Expansion of human mesenchymal stem cells in fibrous bed bioreactor;Ang-Chen Tsai等;《Biochemical Engineering Journal》;20150909;第108卷;第51-57页 * |
Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors;CHRISTINA KROPP等;《Stem Cell Translation Medicine》;20130701;第5卷;第1289-1301页 * |
KHANDAKER SIDDIQUEE等.Billion-Cell Hypoxic Expansion of Human Mesenchymal Stem Cells in BioBLU® 5c Single-Use Vessels.《Bioprocessing Journal》.2015,第14卷(第2期), * |
Also Published As
Publication number | Publication date |
---|---|
CN110106142A (zh) | 2019-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9845455B2 (en) | Method for cell expansion | |
CN112522191B (zh) | 一种间充质干细胞的培养方法 | |
CN110923196B (zh) | 无血清培养基及其制备方法和间充质干细胞的培养方法 | |
CN107164326B (zh) | 一种3D培养自体脂肪MSCs来源的神经前体细胞的方法 | |
CN108315297B (zh) | 一种从脂肪组织中分离、纯化脂肪干细胞的方法 | |
CN105969720A (zh) | 一种人类血管内皮细胞培养液及其培养方法 | |
CN106591224B (zh) | 高纯度鸡前体肌内脂肪细胞的分离纯化及构建其与肌卫星细胞共培养体系的方法 | |
CN110106142B (zh) | 一种制备“百亿”级脂肪源再生细胞的生产工艺 | |
CN113462639B (zh) | 一种分离来源于人类诱导多能干细胞的成纤维细胞的方法及其应用 | |
CN107513519B (zh) | 一种雪旺细胞的培养方法 | |
CN113957048A (zh) | 一种利用脐带血单个核细胞生产自然杀伤细胞的方法 | |
CN111484973B (zh) | 一种脂肪干细胞的纯化方法 | |
CN108324993A (zh) | 一种诱导毛发再生的干细胞复合体、其制备方法及应用 | |
CN112941017A (zh) | 一种诱导人间充质干细胞成脂分化培养基及其制备方法 | |
CN108034634B (zh) | 一种从经血中分离宫内膜间充质干细胞的方法 | |
CN108410796B (zh) | 一种诱导人间充质干细胞向血管内皮细胞分化的方法 | |
CN115125194A (zh) | 一种牦牛前体脂肪细胞的制备方法 | |
WO2021217297A1 (zh) | 一种制备"百亿"级脂肪源再生细胞的生产工艺 | |
CN115029305A (zh) | 猪FAPs细胞分离鉴定方法及FAPs细胞的用途 | |
CN109666642B (zh) | 一种树鼩大脑皮层少突胶质前体细胞体外分离纯化的方法 | |
CN101451122B (zh) | 褐点石斑鱼鳔细胞系的构建方法 | |
Li et al. | A single-use, scalable perfusion bioreactor system | |
CN113073076A (zh) | 一种将多能干细胞分化为瓣膜内皮细胞与瓣膜***的分化方法 | |
CN113151153A (zh) | 一种小鼠腹膜血管周细胞的纯化方法和鉴定方法 | |
CN106434550A (zh) | 一种改良的PPCs细胞培养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 518107 Room 408, building A1, building A1A2, Guangming science and Technology Park, China Merchants Group, Fenghuang community, Fenghuang street, Guangming District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Alpha Biotechnology Co.,Ltd. Address before: 518107 Smart City A1-408, China Merchants Bureau, 3009 Sightseeing Road, Guangming District, Shenzhen City, Guangdong Province Patentee before: Shenzhen Alpha Biotechnology Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Building 1, Block A, Building 15, Guangming Tian'an Yungu Industrial Park, No. 98 Zhenyuan Road, Zhenmei Community, Xinhu Street, Guangming District, Shenzhen City, Guangdong Province, 518107 Patentee after: Shenzhen Alpha Biotechnology Co.,Ltd. Country or region after: China Address before: 518107 408, Building A1, Building A1A2, China Merchants Guangming Science Park, Fenghuang Community, Guangming District, Shenzhen, Guangdong Patentee before: Shenzhen Alpha Biotechnology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |